medigraphic.com
ISSN 1727-897X (Electronic)

2014, Number 2

<< Back Next >>

Medisur 2014; 12 (2)

Health-related quality of life in women with polycystic ovary syndrome

Carazo HB, Lafalla BO, García SR, Gascón ME, Moreno RE, Rojas Pérez-Ezquerra B

Language: Spanish
References: 28
Page: 408-415
PDF size: 162.12 Kb.


ABSTRACT

Polycystic ovary syndrome is the most frequent endocrine and metabolic disorder in women of reproductive age. Its characteristic signs and symptoms are menstrual irregularities, amenorrhea, acne, hirsutism, obesity and infertility. Polycystic ovary syndrome has major effects on long-term health, which can lead to psychological morbidity and decreased quality of life. This paper reviews the current literature on polycystic ovary syndrome and health-related quality of life; in addition, it assesses how some clinical manifestations of polycystic ovary syndrome affect the quality of life of women who suffer this disorder.


REFERENCES

  1. Carvajal R, Herrera C, Porcile A. Espectro fenotípico del síndrome de ovario poliquístico. Rev Chil Obstet Ginecol. 2010 ; 75 (2): 124-32.

  2. Jones GL, Hall JM, Balen AH, Ledger WL. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2008 ; 14 (1): 15-25.

  3. Bremer AA. Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord. 2010 ; 8 (5): 375-94.

  4. Franks S, Berga SL. Does PCOS have developmental origins?. Fertil Steril. 2012 ; 97 (1): 2-6.

  5. Jones GL, Palep M, Ledger WL, Balen AH, Jenkinson C, Campbell MJ, et al. Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes. 2010 ; 8: 149.

  6. Colwell HH, Mathias SD, Pasta DJ, Henning JM, Steege JF. A health-related quality-of-life instruments for symptomatic patients with endometriosis: a validation study. Am J Obstet Gynecol. 1998 ; 179 (1): 47-55.

  7. Trent ME, Rich M, Austin SB, Gordon CM. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2002 ; 156 (6): 556-60.

  8. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998 ; 83 (6): 1976-87.

  9. Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short From-36 (SF-36). Gynecol Endocrinol. 2006 ; 22 (2): 80-86.

  10. Elsenbruch S, Benson S, Hahn S, Tan S, Mann K, Pleger K, et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod. 2006 ; 21 (4): 1092-9.

  11. Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol. 2010 ; 162 (6): 1093-9.

  12. Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update. 2009 ; 15 (4): 477-88.

  13. Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary síndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377-84.

  14. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 ; 19 (1): 41-7.

  15. Azziz R, Carmina E, Dewailly D, Diamanti E, Escobar HF, Futterweit W, et al. Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006 ; 91 (11): 4237-45.

  16. Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women´s quality of life: More than an endocrine disorder. Drug Healthc Patient Saf. 2009 ; 1: 9-15.

  17. Coffey S, Mason H. The Effect of Polycystic Ovary Syndrome on Health-Related Quality of Life. Gynecol Endocrinol. 2003 ; 17 (5): 379-86.

  18. Keegan A, Liao LM, Boyile M. Hirsutism: A psychological analysis. J Health Psychol. 2003 ; 8 (3): 327-45.

  19. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010 ; 8: 41.

  20. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome, body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf). 2007 ; 66 (3): 379-79.

  21. De la Jara Díaz JF, Ortega González C. Síndrome de ovario poliquístico. Revista Mexicana de Medicina de la Reproducción [revista en Internet]. 2011 [ cited 9 May 2013 ] ; 4 (2): [aprox. 20p]. Available from: http://www.revistasmedicasmexicanas.com.mx/d ownload/reproduccion/Octubre-Diciembre2011/R eproduccion 4.4 sindrome.pdf.

  22. Brassard M, AinMelk Y, Baillargeon JP. Basic infertility including polycystic ovary syndrome. Med Clin North Am. 2008 ; 92 (5): 1163-92.

  23. Azziz R, Carmina E, Dewailly D, Diamanti E, Escobar HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009 ; 91 (2): 456-88.

  24. De Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011 ; 17 (4): 495-500.

  25. Wild RA, Carmina E, Diamanti E, Dokras A, Escobar HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010 ; 95 (5): 2038-49.

  26. Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, Demir B, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011 ; 26 (12): 3339-45.

  27. Jedel E, Waern M, Gustafson D, Landen M, Eriksson E, Holm G, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod. 2010 ; 25 (2): 450-6.

  28. Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011 ; 26 (9): 2442-51.




2020     |     www.medigraphic.com